Castle Biosciences, Inc.
NASDAQ:CSTL
19.29 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| 18.245 | -57.466 | -67.138 | -31.292 | -10.284 | 5.277 | -6.367 | -12.37 |
| Depreciation & Amortization
| 15.997 | 12.33 | 10.543 | 3.407 | 0.472 | 0.358 | 0.323 | 0.311 |
| Deferred Income Tax
| 1.401 | -0.223 | -1.877 | -8.736 | 1.397 | -2.28 | 0.272 | -0.163 |
| Stock Based Compensation
| 50.32 | 51.219 | 36.321 | 21.74 | 8.309 | 1.249 | 0.294 | 0.109 |
| Change In Working Capital
| -14.125 | -6.63 | -0.007 | -4.102 | 9.148 | 0.044 | -7.359 | -0.641 |
| Accounts Receivables
| -12.643 | -14.93 | -6.218 | -4.631 | 1.663 | -0.896 | -8.408 | -0.428 |
| Inventory
| -0.193 | -3.962 | -1.68 | 0.327 | -0.98 | -0.355 | -0.578 | -0.116 |
| Accounts Payables
| -4.372 | 5.707 | 0.582 | -0.182 | 0.169 | 0.557 | 0.197 | 0.371 |
| Other Working Capital
| 3.083 | 6.555 | 7.309 | 0.384 | 8.296 | 0.738 | 1.429 | -0.468 |
| Other Non Cash Items
| -6.972 | -4.856 | -19.497 | 33.04 | 0.823 | 2.367 | 0.542 | 0.52 |
| Operating Cash Flow
| 64.866 | -5.626 | -41.655 | -18.983 | 9.865 | 7.015 | -12.295 | -12.234 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -28.326 | -13.621 | -5.632 | -3.483 | -4.751 | -0.937 | -0.277 | -0.495 |
| Acquisitions Net
| 0 | 0 | -26.966 | -63.184 | 0.003 | 0 | 0 | 0 |
| Purchases Of Investments
| -205.729 | -189.075 | -134.689 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 183.9 | 186.5 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0.018 | 0.013 | 0.742 | 0.01 | 0.003 | 0 | 0 | 0 |
| Investing Cash Flow
| -50.137 | -16.183 | -166.545 | -66.657 | -4.748 | -0.937 | -0.277 | -0.495 |
| Financing Activities: | ||||||||
| Debt Repayment
| 9.903 | -0.142 | -0.122 | -0.008 | -27.359 | 20.916 | 5.418 | 8.574 |
| Common Stock Issued
| 0 | 0.269 | 0.833 | 3.898 | 330.041 | 65.931 | 10.42 | 0.293 |
| Common Stock Repurchased
| 0 | -5.134 | -1.688 | -0.781 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -3.764 | -2.156 | 1.637 | 5.429 | 3.208 | 1.441 | 10.383 | 0.293 |
| Financing Cash Flow
| 6.139 | -2.298 | 1.515 | 5.421 | 305.89 | 88.288 | 15.838 | 8.866 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 20.868 | -24.107 | -206.685 | -80.219 | 311.007 | 94.366 | 3.266 | -3.862 |
| Cash At End Of Period
| 119.709 | 98.841 | 122.948 | 329.633 | 409.852 | 98.845 | 4.479 | 1.212 |